Novartis Ag (NVSEF) Retained Earnings (2016 - 2025)
Historic Retained Earnings for Novartis Ag (NVSEF) over the last 17 years, with Q4 2025 value amounting to $45.4 billion.
- Novartis Ag's Retained Earnings rose 486.77% to $45.4 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $45.4 billion, marking a year-over-year increase of 486.77%. This contributed to the annual value of $45.4 billion for FY2025, which is 486.77% up from last year.
- Latest data reveals that Novartis Ag reported Retained Earnings of $45.4 billion as of Q4 2025, which was up 486.77% from $43.6 billion recorded in Q3 2025.
- Novartis Ag's Retained Earnings' 5-year high stood at $66.8 billion during Q4 2021, with a 5-year trough of $37.4 billion in Q3 2023.
- In the last 5 years, Novartis Ag's Retained Earnings had a median value of $47.8 billion in 2021 and averaged $49.3 billion.
- Per our database at Business Quant, Novartis Ag's Retained Earnings surged by 2220.46% in 2022 and then crashed by 3771.5% in 2023.
- Quarter analysis of 5 years shows Novartis Ag's Retained Earnings stood at $66.8 billion in 2021, then dropped by 12.36% to $58.5 billion in 2022, then fell by 21.63% to $45.9 billion in 2023, then dropped by 5.62% to $43.3 billion in 2024, then rose by 4.87% to $45.4 billion in 2025.
- Its Retained Earnings stands at $45.4 billion for Q4 2025, versus $43.6 billion for Q3 2025 and $41.3 billion for Q2 2025.